LuminUltra, an applied molecular diagnostics company, opened its U.S. headquarters in Baltimore, made up of its Technology Development and Distribution Centers of Excellence.
This new facility unites two previously separate locations for the company’s Technology Development and Distribution divisions.
The new location includes more than 14,000 square feet of space for research, development and logistics activities and is the main shipping hub for all North America.
Leased from St. John Properties Inc., the facility is centrally located in the BWI Tech Park with access to key freight, road and air routes. Lacey Johansson of St. John Properties represented the landlord and Mark Deering and Drew White of MacKenzie Commercial Real Estate Services represented the client in this transaction.
The LuminUltra Technology Development team will now have even more tools at their disposal to complete critical research and development tasks to further expand the company’s diagnostics portfolio. Facility improvements include a state-of-the-art clean room and dry room for research involving freeze-dried products such as lyophilized beads, a cold room for work in areas such as protein purification, and significantly enhanced equipment design and engineering capabilities.
The company has invested in multiple operational enhancements over the past year. The new distribution center has been custom designed to meet LuminUltra’s operational needs, resulting in immediate improvements in efficiency and productivity. Combined with a recently upgraded ERP, the company has made significant investments to better facilitate faster workflow and product distribution to customers around the world.
LuminUltra has a more than 25-year history of developing solutions and services that deliver rapid, accurate, actionable feedback for customers that are greatly affected by microbial activity, including biofouling, bioprocessing and biosecurity applications.
The company has been on an accelerated growth trajectory over recent years which has included opening a new Production Center of Excellence in Canada and the acquisition of Florida-based Source Molecular in 2020. In 2021, the company was selected by the Center for Disease Control to provide SARS-CoV-2 wastewater surveillance as part of the CDC’s National Wastewater Surveillance System.